ID: ALA5283029
Chembl Id: CHEMBL5283029
Max Phase: Preclinical
Molecular Formula: C10H5F3INO3
Molecular Weight: 371.05
Associated Items:
Canonical SMILES: O=[N+]([O-])C1=Cc2cccc(I)c2OC1C(F)(F)F
Standard InChI: InChI=1S/C10H5F3INO3/c11-10(12,13)9-7(15(16)17)4-5-2-1-3-6(14)8(5)18-9/h1-4,9H
Standard InChI Key: OINSXVBMFZOPDW-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 371.05 | Molecular Weight (Monoisotopic): 370.9266 | AlogP: 3.23 | #Rotatable Bonds: 1 |
| Polar Surface Area: 52.37 | Molecular Species: ┄ | HBA: 3 | HBD: ┄ |
| #RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.47 | CX LogD: 3.47 |
| Aromatic Rings: 1 | Heavy Atoms: 18 | QED Weighted: 0.43 | Np Likeness Score: -0.42 |
| 1. Jung YH, Shah Q, Lewicki SA, Pramanik A, Gopinatth V, Pelletier J, Sévigny J, Iqbal J, Jacobson KA.. (2022) Synthesis and pharmacological characterization of multiply substituted 2H-chromene derivatives as P2Y6 receptor antagonists., 75 [PMID:36089113] [10.1016/j.bmcl.2022.128981] |
Source(1):
